Synta to fund operations with $35 million stock offering

04/18/2011 | Mass High Tech (Boston)

Synta Pharmaceuticals pulled in $35 million in a stock placement to support its research and development efforts, manufacturing operations and other corporate functions. The biopharmaceutical firm also secured a $2 million loan that it will use to buy laboratory tools to test drug candidates for cancer and chronic inflammatory conditions.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Chief Quality Officer
UnityPoint Clinic
Des Moines, ID
Director, Payer Marketing
Avalere Health
Washington, DC
The Pew Charitable Trusts
Director, Antibiotics and Innovation Project
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX